Peer-reviewed journal articles, case reports, and conference abstracts by Dr. Umut İlhan in the field of pulmonology and chest diseases.
Özden Ş, Tepetam FM, İlhan U, Üstüner T, et al. — Allergologia et Immunopathologia 54(2):117–124 (2026)
Real-world multicenter data demonstrating superior outcomes when combining systemic corticosteroids, antifungal agents, and biologic therapies for ABPA/ABPM compared to monotherapy.
View Articleİlhan U, et al. — Cureus 18(1):e101764 (2026)
An unusual case of ABPA presenting as an FDG-avid upper-lobe mass on PET-CT, closely mimicking primary lung malignancy and highlighting diagnostic challenges in older patients.
View PDFİlhan U, Demirkol B, Çörtük M, Cetinkaya E, et al. — BMC Pulmonary Medicine 26(1):25 (2025)
Landmark study showing that adding BAL to cryo-transbronchial biopsy significantly improves diagnostic yield for interstitial lung diseases, supporting its routine use in ILD workup.
Pehlivan E, Zeren M, Özcan ZB, Karaahmetoğlu FS, Demirkol B, İlhan U, et al. — Sarcoidosis, Vasculitis and Diffuse Lung Diseases 42(1):15942 (2025)
Near-infrared spectroscopy study revealing that peripheral muscle oxygenation in fibrosing ILD patients is limited during exercise, possibly due to increased respiratory muscle blood demand competing with peripheral tissues.
PubMed CentralBeyzanur H, Çiçek Y, Aksoy MY, Erçelik Nİ, Tanrıverdi E, İlhan U — Hamidiye Medical Journal (2024)
Retrospective study of 120 patients showing that the FVC/DLCO ratio alone does not independently predict mortality in ILD patients with concurrent pulmonary hypertension, though the combined condition carries a poor prognosis.
View Articleİlhan U, et al. — Sarcoidosis, Vasculitis and Diffuse Lung Diseases 40(4):e2023049 (2023)
Prospective evaluation of long-term immunosuppressive therapy outcomes in post-COVID-19 ILD, documenting improvements in clinical, functional, and radiological parameters over time.
View ArticleDemirkol B, Gül Ş, Çörtük M, Koç AS, İlhan U, et al. — Hamidiye Medical Journal (2022)
Analysis of 596 COVID-19 patients showing that 80% experienced persistent post-COVID symptoms; advanced age, male sex, and COPD were identified as significant risk factors for hospitalization.
View Articleİlhan U, et al. — Turkish Journal of Medical Sciences 52(5):1478–1485 (2022)
National multicenter genetic screening study revealing that rare alpha-1 antitrypsin deficiency variants are more prevalent than expected among Turkish COPD patients, with clinical implications for targeted therapy.
İlhan U, et al. — Research Square (preprint, under review)
Rare case report documenting sarcoidosis presenting primarily through hematuria — an atypical manifestation that underscores the systemic nature and diverse phenotypes of sarcoidosis.
View PreprintPresented at the European Respiratory Society (ERS) International Congress. Full-text access may require ERS membership.
Conference abstract presented at the ERS International Congress 2025. European Respiratory Journal 66, Suppl. 69.
View Abstract (ERS)Conference abstract presented at the ERS International Congress 2024. European Respiratory Journal 64, Suppl. 68.
View Abstract (ERS)Conference abstract presented at the ERS International Congress 2023. European Respiratory Journal 62, Suppl. 67.
View Abstract (ERS)All publications listed above involve Dr. Umut İlhan as author or co-author.